SEARCH
Immunome, Inc.
Wynnewood, PA 19096 USA
Phone
Fax
Research Sector Biotech Specialty Pharma
Summary Description Provides unbiased immune response method to combat infectious disease, neurological, cancer, and autoimmune diseases.
Management Timothy Pelura, CEO; Scott Dessain, Chief Scientific Officer; George Hobbs, SVP Corporate Development and General Counsel Click here for Financial Data
Keywords: infectious disease, immune, cancer, biodefense, neurological, vaccine
Updated: Sept. 12, 2014
Description
Immunome is a discovery stage biopharmaceutical company that has created a proprietary Native Human Monoclonal Antibody (N-huMAB) platform. N-huMAbs are in the exact structures created by nature and ......view more
Products / Services
Native human antibodies for therapy and diagnosis.......view more
Technology / Differentiation
Human hybridoma platform for native human antibody isolation....view more
Strategy
Clinical development through POC studies and multiple partnerships/collaborations on proprietary targets to generate non-dilutive capital....view more
Revenue / Funding
$1.9M in angel and grants to date. Currently raising $650K remainder of seed financing. Partnership dollars are supporting internal cancer program....view more
Status
Preclinical stage....view more